Resveratrol potentiates the effect of dexamethasone in rat model of acute lung inflammation

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 773-779

  Sadarani, Bhakti N ^a   Majumdar, Anuradha S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Cigarette smoke; Dexamethasone; Lipopolysaccharide; Matrix metalloproteinase 9; Resveratrol

Indexed keywords

CIGARETTE SMOKE; DEXAMETHASONE; GELATINASE B; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; RESVERATROL; SIRTINOL; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; LIPOPOLYSACCHARIDE, ESCHERICHIA COLI 0111 B4; SMOKE; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; HISTOPATHOLOGY; LEUKOCYTE COUNT; LIPID PEROXIDATION; LUNG FLUID; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; RAT; SMOKING; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; DISEASE MODEL; IMMUNOLOGY; SMOKE; SPRAGUE DAWLEY RAT; TOBACCO; TOXICITY;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; LIPOPOLYSACCHARIDES; MALE; PNEUMONIA; RATS, SPRAGUE-DAWLEY; SMOKE; STILBENES; TOBACCO PRODUCTS;

EID: 84939495624     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.07.038     Document Type: Article

References (45)

1. B. Antus, G. Harnasi, O. Drozdovszky, and I. Barta Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde Respirology 19 2014 74 79
2. B. Antus, and Z. Kardos Oxidative stress in COPD: molecular background and clinical monitoring Curr. Med. Chem. 22 2015 627 650
3. P.J. Barnes Cellular and molecular mechanisms of chronic obstructive pulmonary disease Clin. Chest Med. 35 2014 71 86
4. G. Caramori, I.M. Adcock, A. Di Stefano, and K.F. Chung Cytokine inhibition in the treatment of COPD Int. J. Chron. Obstruct. Pulmon. Dis. 9 2014 397 412
5. G. Chen, J. Tang, Z. Ni, Q. Chen, Z. Li, W. Yang, and et al. Antiasthmatic effects of resveratrol in ovalbumin-induced asthma model mice involved in the upregulation of PTEN Biol. Pharm. Bull. 38 2015 507 513
6. J. Chen, H. Zhou, J. Wang, B. Zhang, F. Liu, J. Huang, and et al. Therapeutic effects of resveratrol in a mouse model of HDM-induced allergic asthma Int. Immunopharmacol. 25 2015 43 48
7. A. Churg, M. Cosio, and J.L. Wright Mechanisms of cigarette smoke-induced COPD: insights from animal models Am. J. Physiol. Lung Cell. Mol. Physiol. 294 2008 L612 L631
8. C. Cipollina, S. Di Vincenzo, S. Gerbino, L. Siena, M. Gjomarkaj, and E. Pace Dual anti-oxidant and anti-inflammatory actions of the electrophilic cyclooxygenase-2-derived 17-oxo-DHA in lipopolysaccharide- and cigarette smoke-induced inflammation Biochim. Biophys. Acta 1840 2014 2299 2309
9. E.L. Hardaker, M.S. Freeman, N. Dale, P. Bahra, F. Raza, K.H. Banner, and et al. Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung Br. J. Pharmacol. 160 2010 1985 1996
10. J.D. Hasday, R. Bascom, J.J. Costa, T. Fitzgerald, and W. Dubin Bacterial endotoxin is an active component of cigarette smoke CHEST J. 115 1999 829 835
11. C. Herr, G. Han, D. Li, T. Tschernig, Q.T. Dinh, C. Beisswenger, and et al. Combined exposure to bacteria and cigarette smoke resembles characteristic phenotypes of human COPD in a murine disease model Exp. Toxicol. Pathol. 67 2015 261 269
12. K. Hoenderdos, and A. Condliffe The neutrophil in chronic obstructive pulmonary disease. Too little, too late or too much, too soon? Am. J. Respir. Cell Mol. Biol. 48 2013 531 539
13. Y.X. Hu, H. Cui, L. Fan, X.J. Pan, J.H. Wu, S.Z. Shi, and et al. Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation Can. J. Physiol. Pharmacol. 91 2013 1044 1054
14. J.-w. Hwang, S. Chung, I.K. Sundar, H. Yao, G. Arunachalam, M.W. McBurney, and et al. Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: implication in pathogenesis of COPD Arch. Biochem. Biophys. 500 2010 203 209
15. J. Knobloch, B. Sibbing, D. Jungck, Y. Lin, K. Urban, E. Stoelben, and et al. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease J. Pharmacol. Exp. Ther. 335 2010 788 798
16. E. Kolaczkowska, and P. Kubes Neutrophil recruitment and function in health and inflammation Nat. Rev. Immunol. 13 2013 159 175
17. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
18. K.M. Lee, R.A. Renne, S.J. Harbo, M.L. Clark, R.E. Johnson, and K.M. Gideon 3-Week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice Inhal. Toxicol. 19 2007 23 35
19. T. Li, A. Molteni, P. Latkovich, W. Castellani, and R.C. Baybutt Vitamin A depletion induced by cigarette smoke is associated with the development of emphysema in rats J. Nutr. 133 2003 2629 2634
20. T. Li, J. Zhang, J. Feng, Q. Li, L. Wu, Q. Ye, and et al. Resveratrol reduces acute lung injury in a LPS-induced sepsis mouse model via activation of Sirt1 Mol. Med. Rep. 7 2013 1889 1895
21. R. Linder, E. Rönmark, J. Pourazar, A. Behndig, A. Blomberg, and A. Lindberg Serum metalloproteinase-9 is related to COPD severity and symptoms-cross-sectional data from a population based cohort-study Respir. Res. 16 2015 28
22. C. Ma, Y. Wang, L. Dong, M. Li, and W. Cai Anti-inflammatory effect of resveratrol through the suppression of NF-κB and JAK/STAT signaling pathways Acta Biochim. Biophys. Sin. 47 2015 207 213
23. J. Milara, J. Lluch, P. Almudever, J. Freire, Q. Xiaozhong, and J. Cortijo Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease J. Allergy Clin. Immunol. 134 2014 314 322
24. S. Nakamura, K. Yanagihara, N. Araki, K. Yamada, Y. Morinaga, K. Izumikawa, and et al. High-dose tobramycin inhibits lipopolysaccharide-induced MUC5AC production in human lung epithelial cells Eur. J. Pharmacol. 659 2011 67 71
25. Y.C. Nie, H. Wu, P.B. Li, Y.L. Luo, C.C. Zhang, J.G. Shen, and et al. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease Pulm. Pharmacol. Ther. 25 2012 349 356
26. L. Nissinen, and V.M. Kahari Matrix metalloproteinases in inflammation Biochim. Biophys. Acta 1840 2014 2571 2580
27. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
28. O.M. Ozdemir, E. Gozkeser, F. Bir, and C. Yenisey The effects of resveratrol on hyperoxia-induced lung injury in neonatal rats Pediatr. Neonatol. 55 2014 352 357
29. E. Papakonstantinou, M. Tamm, M. Roth, and D. Stolz MMP-9 expression and activity is increased in the BAL of patients with acute exacerbation of COPD Eur. Respir. J. 40 2012 P790
30. E.J. Park, and J.M. Pezzuto The pharmacology of resveratrol in animals and humans Biochim. Biophys. Acta 1852 2015 1071 1113
31. I. Rahman, and I.M. Adcock Oxidative stress and redox regulation of lung inflammation in COPD Eur. Respir. J. 28 2006 219 242
32. S.A. Rieder, P. Nagarkatti, and M. Nagarkatti Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury Br. J. Pharmacol. 167 2012 1244 1258
33. J.L. Shergis, Y.M. Di, A.L. Zhang, R. Vlahos, R. Helliwell, J.M. Ye, and et al. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease Complement. Ther. Med. 22 2014 944 953
34. J.L. Simpson, V.M. McDonald, K.J. Baines, K.M. Oreo, F. Wang, P.M. Hansbro, and et al. Influence of age, past smoking, and disease severity on TLR2, neutrophilic inflammation, and MMP-9 levels in COPD Mediators Inflamm. 2013 2013 462934
35. M. Toth, A. Sohail, and R. Fridman Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography Methods Mol. Biol. 878 2012 121 135
36. B.M. Fischer, E. Pavlisko, and J.A. Voynow Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation Int. J. Chron. Obstruct. Pulmon. Dis. 6 2011 413 421
37. R.M. Tuder, and I. Petrache Pathogenesis of chronic obstructive pulmonary disease J. Clin. Invest. 122 2012 2749 2755
38. R. Vlahos, and S. Bozinovski Recent advances in pre-clinical mouse models of COPD Clin. Sci. (Lond.) 126 2014 253 265
39. T. Wang, L.-L. Guo, G.-M. He, F. Luo, and F.-Q. Wen Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition Eur. Respir. J. 40 2012 P3907
40. L.G. Wood, P.A. Wark, and M.L. Garg Antioxidant and anti-inflammatory effects of resveratrol in airway disease Antioxid. Redox Signal. 13 2010 1535 1548
41. J. Xu, Y.T. Zhu, G.Z. Wang, D. Han, Y.Y. Wu, D.X. Zhang, and et al. The PPARgamma agonist, rosiglitazone, attenuates airway inflammation and remodeling via heme oxygenase-1 in murine model of asthma Acta Pharmacol. Sin. 36 2015 171 178
42. H.X. Zhang, G.L. Duan, C.N. Wang, Y.Q. Zhang, X.Y. Zhu, and Y.J. Liu Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress Pulm. Pharmacol. Ther. 27 2014 150 155
43. L. Zhang, X. Guo, W. Xie, Y. Li, M. Ma, T. Yuan, and et al. Resveratrol exerts an anti-apoptotic effect on human bronchial epithelial cells undergoing cigarette smoke exposure Mol. Med. Rep. 11 2015 1752 1758
44. A. Zhu, D. Ge, J. Zhang, Y. Teng, C. Yuan, M. Huang, and et al. Sputum myeloperoxidase in chronic obstructive pulmonary disease Eur. J. Med. Res. 19 2014 12
45. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1 1976 248 254